Phase IIa Pilot Study Evaluating the Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers
Latest Information Update: 08 Jan 2024
At a glance
- Drugs Atoltivimab/maftivimab/odesivimab (Primary) ; RVSV-S-GP/VP40 vaccine (Primary)
- Indications Ebola virus infections
- Focus Pharmacodynamics
Most Recent Events
- 25 Jan 2022 New trial record